Literature DB >> 16722657

5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.

Xuesen Fan1, Xinying Zhang, Longhu Zhou, Kathy A Keith, Earl R Kern, Paul F Torrence.   

Abstract

To provide potential new leads for the treatment of orthopoxvirus infections, the 5-position of the pyrimidine nucleosides have been modified with a gem diether moiety to yield the following new nucleosides: 5-(dimethoxymethyl)-2'-deoxyuridine (2b), 5-(diethoxymethyl)-2'-deoxyuridine (3b), 5-formyl-2'-deoxyuridine ethylene acetal (4b), and 5-formyl-2'-deoxyuridine propylene acetal (5b). These were evaluated in human foreskin fibroblast cells challenged with the vaccinia virus or cowpox virus. Of the four gem diether nucleosides, only the dimethyl gem diether congener showed significant antiviral activity against both viruses. This antiviral activity did not appear to be related to the decomposition to the 5-formyl-2'-deoxyuridine, which was itself devoid of anti-orthopoxvirus activity in these assays. Moreover, at the pH of the in vitro assays, 2b was very stable with a decomposition (to aldehyde) half-life of >15 d. The anti-orthopoxvirus activity of pyrimidine may be favored by the introduction of hydrophilic moieties to the 5-position side chain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722657      PMCID: PMC4262926          DOI: 10.1021/jm0601710

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  70 in total

1.  The problem of biological weapons: next steps for the nation.

Authors:  T O'Toole
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

2.  Bioterrorism. Vaccines for biodefense: a system in distress.

Authors:  J Cohen; E Marshall
Journal:  Science       Date:  2001-10-19       Impact factor: 47.728

3.  Infectious diseases. New biodefense splurge creates hotbeds, shatters dreams.

Authors:  Martin Enserink
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

4.  Biodefense cost and consequence.

Authors:  Laurie Goodman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 5.  Smallpox: a vulnerable specter.

Authors:  Martin Eichner; Markus Schwehm
Journal:  Epidemiology       Date:  2004-05       Impact factor: 4.822

6.  [Hevizos ointment efficacy in view of molecular pharmacology].

Authors:  L Otvös; F H Tüdös
Journal:  Acta Pharm Hung       Date:  1993-07

7.  Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.

Authors:  Stephanie L Ciesla; Julissa Trahan; W Brad Wan; James R Beadle; Kathy A Aldern; George R Painter; Karl Y Hostetler
Journal:  Antiviral Res       Date:  2003-08       Impact factor: 5.970

8.  Modified polynucleotides. VII. Impaired integrity of a synthetic DNA containing the antiherpetic agent 5-isopropyl-2'-deoxyuridine.

Authors:  J Sági; A Szabolcs; A Szemźó; L Otvös
Journal:  Nucleic Acids Res       Date:  1986-04-25       Impact factor: 16.971

9.  The 5-nitrofuran-2-ylmethylidene group as a potential bioreductively activated prodrug system for diol-containing drugs.

Authors:  N P Mahmud; S W Garrett; M D Threadgill
Journal:  Anticancer Drug Des       Date:  1998-09

Review 10.  Bioterrorism and children: unique concerns with infection control and vaccination.

Authors:  Kay B Leissner; Robert S Holzman; Mary Ellen McCann
Journal:  Anesthesiol Clin North Am       Date:  2004-09
View more
  8 in total

1.  Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analogues.

Authors:  Xinying Zhang; Adel Amer; Xuesen Fan; Jan Balzarini; Johan Neyts; Erik De Clercq; Mark Prichard; Earl Kern; Paul F Torrence
Journal:  Bioorg Chem       Date:  2006-12-02       Impact factor: 5.275

2.  Toward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structure.

Authors:  Xuesen Fan; Xinying Zhang; Longhu Zhou; Kathy A Keith; Mark N Prichard; Earl R Kern; Paul F Torrence
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

3.  Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.

Authors:  Mark N Prichard; Kathy A Keith; Mary P Johnson; Emma A Harden; Alexis McBrayer; Ming Luo; Shihong Qiu; Debasish Chattopadhyay; Xuesen Fan; Paul F Torrence; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

4.  Ionic liquid promoted preparation of 4H-thiopyran and pyrimidine nucleoside-thiopyran hybrids through one-pot multi-component reaction of thioamide.

Authors:  Xinying Zhang; Xiaoyan Li; Xuesen Fan; Xia Wang; Dongfang Li; Guirong Qu; Jianji Wang
Journal:  Mol Divers       Date:  2008-12-09       Impact factor: 2.943

5.  Antiviral Activity of 4'-thioIDU and Thymidine Analogs against Orthopoxviruses.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Viruses       Date:  2010-09-16       Impact factor: 5.818

6.  [(2R,3S,5R)-3-Acet-oxy-5-(5-formyl-2,4-dioxo-1,2,3,4-tetra-hydro-pyrimidin-1-yl)-2,3,4,5-tetra-hydro-furan-2-yl]methyl acetate.

Authors:  Xue-Fei Jia; Nan Liu; Liang-Liang Fang; Xin-Ying Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-12

Review 7.  Drug Development against Smallpox: Present and Future.

Authors:  Déborah Delaune; Frédéric Iseni
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.938

8.  Ionic liquid-promoted multi-component reaction: novel and efficient preparation of pyrazolo[3,4-b]pyridinone, pyrazolo[3,4-b]-quinolinone and their hybrids with pyrimidine nucleoside.

Authors:  Xinying Zhang; Dongfang Li; Xuesen Fan; Xia Wang; Xiaoyan Li; Guirong Qu; Jianji Wang
Journal:  Mol Divers       Date:  2009-06-12       Impact factor: 3.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.